February 21, 2022
Combining a Web3 IP market, venture capital, and a decentralized autonomous organization (DAO), three companies have banded together to create a new decentralized science ecosystem. The full press release is included here. Feb. 21, 2022, Switzerland — Molecule, a biotech IP Web3 marketplace, announces a tripartite partnership with Apollo Health Ventures, a leading longevity-focused venture...
December 02, 2021
Apollo Health Ventures, a venture capitalist firm focusing on rejuvenation biotechnology, has raised $180 million in order to fund companies developing interventions that target age-related diseases. We have included the full press release below. Apollo Health Ventures Closes $180 Million Fund to Drive Breakthrough Innovations Combating Age-related Diseases BOSTON and BERLIN, December 1, 2021 –...
May 06, 2020
We had the opportunity to speak to Apollo Health Ventures about the Moonshot Venture Fellowship and about the aging research field in general from the perspective of a venture capital firm. Apollo Health Ventures is a life science venture capital firm and life science company builder working across Europe and North America. Apollo is unique...
March 06, 2019
Samsara Therapeutics has completed a seed financing round in collaboration with Apollo Ventures, a venture capital company and biotech incubator that supports longevity research and treatments for age-related diseases. Samsara Therapeutics, Inc. ("Samsara,") a platform biotechnology startup engaged in the discovery and development of compounds that address the primary molecular causes of aging, announced today...